Brief: Solara Active Pharma Sciences Says FDA Informed Co About Classifying Manufacturing Site At Cuddalore As "Official Action Indicated"
23/06/2020 06:21
June 23 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* SOLARA ACTIVE PHARMA SCIENCES LTD SAYS US FDA INFORMED CO
ABOUT
CLASSIFYING MANUFACTURING SITE AT CUDDALORE AS "OFFICIAL ACTION
INDICATED"
* SOLARA ACTIVE PHARMA SCIENCES LTD SAYS RECLASSIFICATION OF
CUDDALORE SITE WILL NOT IMPACT BUSINESS CONTINUITY FOR FY21
* SOLARA ACTIVE PHARMA SCIENCES LTD SAYS COMPANY CONTINUES
TO
MAINTAIN ITS FY21 GUIDANCE BOTH ON REVENUES AND EBITDA
Source text for Eikon: ID:nBSE62N4hc
Further company coverage: SOLA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees